Heavy metals induce phosphorylation of the Bcl-2 protein by Jun N-terminal kinase

Biological Chemistry

Volumn 390, Issue 1, 2009, Pages 49-58

  Ondroušková, Eva ^a   Slováčková, Jana ^a,b   Pelková, Vendula ^a,c   Procházková, Jiřina ^a,d   Souček, Karel ^d   Beneš, Petr ^a   Šmarda, Jan ^a  

^a MASARYK UNIVERSITY   (Czech Republic)

^b UNIVERSITY HOSPITAL BRNO   (Czech Republic)

^c CHARLES UNIVERSITY   (Czech Republic)

^d INSTITUTE OF BIOPHYSICS   (Czech Republic)

Author keywords

Bcl 2; Heavy metals; Jun N terminal kinase; Phosphorylation; Posttranslational modification

Indexed keywords

HEAVY METAL; PROTEIN BCL 2; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ARTICLE; CELL CYCLE G2 PHASE; CELL DEATH; CONTROLLED STUDY; ELECTROPHORESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

ANIMALS; APOPTOSIS; CELL LINE, TUMOR; ELECTROPHORESIS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; METALS, HEAVY; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTO-ONCOGENE PROTEINS C-BCL-2; SIGNAL TRANSDUCTION; STRESS, PHYSIOLOGICAL; ZINC;

EID: 58249103901     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/BC.2009.007     Document Type: Article

References (53)

1. Bassik, M.C., Scorrano, L., Oakes, S.A., Pozzan, T., and Korsmeyer, S.J. (2004). Phosphorylation of BCL-2 regulates ER Ca2+ homeostasis and apoptosis. EMBO J. 23, 1207-1216.
2. Ben-Bassat, H., Hartzstark, Z., Levitzki, R., Klein, B.Y., Shlomai, Z., Gazit, A., and Levitzki, A. (2002). Tyrosine kinase inhibitors suppress the growth of non-hodgkin B lymphomas. J. Pharmacol. Exp. Ther. 303, 163-171.
3. Blagosklonny, M.V. (2001). Unwinding the loop of Bcl-2 phosphorylation. Leukemia 15, 869-874.
4. Breitschopf, K., Haendeler, J., Malchow, P., Zeiher, A.M., and Dimmeler, S. (2000). Posttranslational modification of Bcl-2 facilitates its proteasome-dependent degradation: molecular characterization of the involved signaling pathway. Mol. Cell. Biol. 20, 1886-1896.
5. Calastretti, A., Bevilacqua, A., Ceriani, C., Vigano, S., Zancai, P., Capaccioli, S., and Nicolin, A. (2001). Damaged microtubules can inactivate BCL-2 by means of the mTOR kinase. Oncogene 20, 6172-6180.
6. Chang, B.S., Minn, A.J., Muchmore, S.W., Fesik, S.W., and Thompson, C.B. (1997). Identification of a novel regulatory domain in Bcl-X(L) and Bcl-2. EMBO J. 16, 968-977.
7. Chen, D., Cui, Q.C., Yang, H., and Dou, Q.P. (2006). Disulfiram, a clinically used anti-alcoholism drug and copper-binding agent, induces apoptotic cell death in breast cancer cultures and xenografts via inhibition of the proteasome activity. Cancer Res. 66, 10425-10433.
8. Cleary, M.L., Smith, S.D., and Sklar, J. (1986). Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation. Cell 47, 19-28.
9. De Chiara, G., Marcocci, M.E., Torcia, M., Lucibello, M., Rosini, P., Bonini, P., Higashimoto, Y., Damonte, G., Armirotti, A., Amodei, S., et al. (2006). Bcl-2 Phosphorylation by p38 MAPK: identification of target sites and biologic consequences. J. Biol. Chem. 281, 21353-21361.
10. Deng, X., Ruvolo, P., Carr, B., and May, W.S. Jr. (2000). Survival function of ERK1/2 as IL-3-activated, staurosporine-resistant Bcl2 kinases. Proc. Natl. Acad. Sci. USA 97, 1578-1583.
11. Deng, X., Gao, F., Flagg, T., and May, W.S. Jr. (2004). Mono- and multisite phosphorylation enhances Bcl2's antiapoptotic function and inhibition of cell cycle entry functions. Proc. Natl. Acad. Sci. USA 101, 153-158.
12. Du, L., Lyle, C.S., and Chambers, T.C. (2005). Characterization of vinblastine-induced Bcl-xL and Bcl-2 phosphorylation: evidence for a novel protein kinase and a coordinated phosphorylation/ dephosphorylation cycle associated with apoptosis induction. Oncogene 24, 107-117.
13. 2+ induces stimulation of the c-Jun N-terminal kinase signaling pathway through phosphoinositide 3-Kinase. Mol. Pharmacol. 59, 981-986.
14. Fang, G., Chang, B.S., Kim, C.N., Perkins, C., Thompson, C.B., and Bhalla, K.N. (1998). 'Loop' domain is necessary for taxol-induced mobility shift and phosphorylation of Bcl-2 as well as for inhibiting taxol-induced cytosolic accumulation of cytochrome c and apoptosis. Cancer Res. 58, 3202-3208.
15. Filippovich, I.V., Sorokina, N.I., Lisbona, A., Cherel, M., and Chatal, J.F. (2001). Radiation-induced apoptosis in human myeloma cell line increases BCL-2/BAX dimer formation and does not result in BAX/BAX homodimerization. Int. J. Cancer 92, 651-660.
16. Furukawa, Y., Iwase, S., Kikuchi, J., Terui, Y., Nakamura, M., Yamada, H., Kano, Y., and Matsuda, M. (2000). Phosphorylation of Bcl-2 protein by CDC2 kinase during G2/M phases and its role in cell cycle regulation. J. Biol. Chem. 275, 21661-21667.
17. Gross, A., Jockel, J., Wei, M.C., and Korsmeyer, S.J. (1998). Enforced dimerization of BAX results in its translocation, mitochondrial dysfunction and apoptosis. EMBO J. 17, 3878-3885.
18. Haldar, S., Jena, N., and Croce, C.M. (1995). Inactivation of Bcl-2 by phosphorylation. Proc. Natl. Acad. Sci. USA 92, 4507-4511.
19. Hallin, U., Kondo, E., Ozaki, Y., Hagberg, H., Shibasaki, F., and Blomgren, K. (2006). Bcl-2 phosphorylation in the BH4 domain precedes caspase-3 activation and cell death after neonatal cerebral hypoxic-ischemic injury. Neurobiol. Dis. 21, 478-486.
20. Inoshita, S., Takeda, K., Hatai, T., Terada, Y., Sano, M., Hata, J., Umezawa, A., and Ichijo, H. (2002). Phosphorylation and inactivation of myeloid cell leukemia 1 by JNK in response to oxidative stress. J. Biol. Chem. 277, 43730-43734.
21. Knapp, L.T. and Klann, E. (2000). Superoxide-induced stimulation of protein kinase C via thiol modification and modulation of zinc content. J. Biol. Chem. 275, 24136-24145.
22. Kondo, E., Miyake, T., Shibata, M., Kimura, T., Iwagaki, H., Nakamura, S., Tanaka, T., Ohara, N., Ichimura, K., Oka, T., et al. (2005). Expression of phosphorylated Ser70 of Bcl-2 correlates with malignancy in human colorectal neoplasms. Clin. Cancer Res. 11, 7255-7263.
23. Kondoh, M., Tasaki, E., Araragi, S., Takiguchi, M., Higashimoto, M., Watanabe, Y., and Sato, M. (2002). Requirement of caspase and p38MAPK activation in zinc-induced apoptosis in human leukemia HL-60 cells. Eur. J. Biochem. 269, 6204-6211.
24. Krajewski, S., Tanaka, S., Takayama, S., Schibler, M.J., Fenton, W., and Reed, J.C. (1993). Investigation of the subcellular distribution of the bcl-2 oncoprotein: residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes. Cancer Res. 53, 4701-4714.
25. Kyriakis, J.M. and Avruch, J. (1990). pp54 microtubule-associated protein 2 kinase. A novel serine/threonine protein kinase regulated by phosphorylation and stimulated by poly-L-lysine. J. Biol. Chem. 265, 17355-17363.
26. Kyriakis, J.M., Banerjee, P., Nikolakaki, E., Dai, T., Rubie, E.A., Ahmad, M.F., Avruch, J., and Woodgett, J.R. (1994). The stress-activated protein kinase subfamily of c-Jun kinases. Nature 369, 156-160.
27. Li, H., Zhu, H., Xu, C.J., and Yuan, J. (1998). Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94, 491-501.
28. Li, D., Ueta, E., Kimura, T., Yamamoto, T., and Osaki, T. (2004). Reactive oxygen species (ROS) control the expression of Bcl-2 family proteins by regulating their phosphorylation and ubiquitination. Cancer Sci. 95, 644-650.
29. Lin, S.S., Bassik, M.C., Suh, H., Nishino, M., Arroyo, J.D., Hahn, W.C., Korsmeyer, S.J., and Roberts, T.M. (2006). PP2A regulates BCL-2 phosphorylation and proteasome-mediated degradation at the endoplasmic reticulum. J. Biol. Chem. 281, 23003-23012.
30. Ling, Y.H., Jiang, J.D., Holland, J.F., and Perez-Soler, R. (2002a). Arsenic trioxide produces polymerization of microtubules and mitotic arrest before apoptosis in human tumor cell lines. Mol. Pharmacol. 62, 529-538.
31. Ling, Y.H., Liebes, L., Ng, B., Buckley, M., Elliott, P.J., Adams, J., Jiang, J.D., Muggia, F.M., and Perez-Soler, R. (2002b). PS-341, a novel proteasome inhibitor, induces Bcl-2 phosphorylation and cleavage in association with G2-M phase arrest and apoptosis. Mol. Cancer Ther. 1, 841-849.
32. Lynch, C.J., Patson, B.J., Goodman, S.A., Trapolsi, D., and Kimball, S.R. (2001). Zinc stimulates the activity of the insulinand nutrient-regulated protein kinase mTOR. Am. J. Physiol. Endocrinol. Metab. 281, E25-34.
33. Manning, A.M. and Davis, R.J. (2003). Targeting JNK for therapeutic benefit: from junk to gold? Nat. Rev. Drug Discov. 2, 554-565.
34. Matsuyoshi, S., Shimada, K., Nakamura, M., Ishida, E., and Konishi, N. (2006). Bcl-2 phosphorylation has pathological significance in human breast cancer. Pathobiology 73, 205-212.
35. May, W.S., Tyler, P.G., Ito, T., Armstrong, D.K., Qatsha, K.A., and Davidson, N.E. (1994). Interleukin-3 and bryostatin-1 mediate hyperphosphorylation of BCL2a in association with suppression of apoptosis. J. Biol. Chem. 269, 26865-26870.
36. Miyoshi, N., Uchida, K., Osawa, T., and Nakamura, Y. (2004). A link between benzyl isothiocyanate-induced cell cycle arrest and apoptosis: involvement of mitogen-activated protein kinases in the Bcl-2 phosphorylation. Cancer Res. 64, 2134-2142.
37. Moscovici, C., Zeller, N., and Moscovici, M.G. (1982). Continuous lines of AMV-transformed non-producer cells: growth and oncogenic potential in the chick embryo. In: Expression of Differentiated Function in Cancer cells, R.F. Revoltella, C. Basilico, R.C. Gallo, G.M. Pontieri, G. Rovera and J.H. Subak-Sharpe, eds. (New York, USA: Raven Press), pp. 325-449.
38. Perry, D.K., Smyth, M.J., Stennicke, H.R., Salvesen, G.S., Duriez, P., Poirier, G.G., and Hannun, Y.A. (1997). Zinc is a potent inhibitor of the apoptotic protease, caspase-3. A novel target for zinc in the inhibition of apoptosis. J. Biol. Chem. 272, 18530-18533.
39. Reed, J.C. (1998). Bcl-2 family proteins. Oncogene 17, 3225-3236.
40. Ruvolo, P.P., Deng, X., Carr, B.K., and May, W.S. (1998). A functional role for mitochondrial protein kinase Calpha in Bcl2 phosphorylation and suppression of apoptosis. J. Biol. Chem. 273, 25436-25442.
41. Ryabinina, O.P., Subbian, E., and Iordanov, M.S. (2006). D-MEKK1, the Drosophila orthologue of mammalian MEKK4/MTK1, and Hemipterous/D-MKK7 mediate the activation of D-JNK by cadmium and arsenite in Schneider cells. BMC Cell Biol. 7, 7.
42. Saraiva, L., Silva, R.D., Pereira, G., Goncalves, J., and Corte-Real, M. (2006). Specific modulation of apoptosis and Bcl-xL phosphorylation in yeast by distinct mammalian protein kinase C isoforms. J. Cell Sci. 119, 3171-3181.
43. Scatena, C.D., Stewart, Z.A., Mays, D., Tang, L.J., Keefer, C.J., Leach, S.D., and Pietenpol, J.A. (1998). Mitotic phosphorylation of Bcl-2 during normal cell cycle progression and Taxol-induced growth arrest. J. Biol. Chem. 273, 30777-30784.
44. Schinzel, A., Kaufmann, T., and Borner, C. (2004). Bcl-2 family members: integrators of survival and death signals in physiology and pathology [corrected]. Biochim. Biophys. Acta 1644, 95-105.
45. Smarda, J. and Lipsick, J.S. (1993). Dicistronic selection for nuclear proteins in living animal cells. Gene 137, 145-149.
46. Srivastava, R.K., Srivastava, A.R., Korsmeyer, S.J., Nesterova, M., Cho-Chung, Y.S., and Longo, D.L. (1998). Involvement of microtubules in the regulation of Bcl2 phosphorylation and apoptosis through cyclic AMP-dependent protein kinase. Mol. Cell. Biol. 18, 3509-3517.
47. Torriglia, A., Perani, P., Brossas, J.Y., Altairac, S., Zeggai, S., Martin, E., Treton, J., Courtois, Y., and Counis, M.F. (2000). A caspase-independent cell clearance program. The LEI/L-DNase II pathway. Ann. N.Y. Acad. Sci. 926, 192-203.
48. Vindelov, L.L. (1977). Flow microfluorometric analysis of nuclear DNA in cells from solid tumors and cell suspensions. A new method for rapid isolation and straining of nuclei. Virchow's Arch. B Cell Pathol. 24, 227-242.
49. Walter, L. and Hajnoczky, G. (2005). Mitochondria and endoplasmic reticulum: the lethal interorganelle cross-talk. J. Bioenerg. Biomembr. 37, 191-206.
50. Wei, Q., Wang, J., Wang, M.H., Yu, F., and Dong, Z. (2004). Inhibition of apoptosis by Zn2q in renal tubular cells following ATP depletion. Am. J. Physiol. Renal Physiol. 287, F492-500.
51. 2/M. Mol. Cell. Biol. 19, 8469-8478.
52. L. Cell 87, 619-628.
53. Zhang, B., Zhang, Y., Dagher, M.C., and Shacter, E. (2005). Rho GDP dissociation inhibitor protects cancer cells against drug-induced apoptosis. Cancer Res. 65, 6054-6062.